This dependency may be related to differences in specific transcription factors regulating RASSF4 (such as ZF5, Pax-5, and AHR) across different cancers and their interactions with DNMT, which promote site-specific methylation [49,65]. The gene discussed is RASSF4; the disease is cancer.